Tag Archive for USANA

Hot Business News Today

USANA Acquires Network Marketing Company Oola

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) today announced the acquisition of two companies—Rise Bar and Oola.

“The acquisition of these emerging companies is part of USANA’s long-term growth strategy”

These emerging companies share USANA’s health and wellness focus while offering distinct channels or products. Rise Bar manufactures and sells high-quality protein bars that are formulated to help customers achieve their health goals through clean and simple ingredients.
Oola is an emerging direct selling company that offers a personal development framework that helps individuals create a life of balance, growth, and purpose.
Although Rise Bar and Oola will continue to operate and grow independently, USANA plans to leverage the knowledge, experience, and technology of these companies to advance USANA’s core business. Likewise, USANA will utilize its assets and resources to facilitate growth for Rise Bar and Oola.
“The acquisition of these emerging companies is part of USANA’s long-term growth strategy,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“We are committed to improving the health and wellness of individuals around the world. While USANA is a leader in many aspects, we recognize that we can accelerate this effort and reach more individuals through strategic acquisitions that align with our corporate values and mission.
“Both Rise

Read more...

Hot Business News Today

USANA Q3 Revenue Down 15 % To $233 Million

by  •  • 0 Comments

USANA Health Sciences, Inc. announced financial results for its fiscal third quarter ended October 1, 2022. Key Financial & Operating Results:
Third quarter net sales were $233 million as compared with $274 million during the third quarter of the prior year. Third quarter diluted EPS totaled $0.78 versus $1.36 during the third quarter of 2021. Company revises fiscal 2022 net sales and diluted EPS outlook to $955 million to $975 million and $3.15 to $3.40, respectively.
Q3 2022 Financial Performance – Consolidated Results
Net Sales $233 million

-15% vs. prior-year quarter
-9% constant currency vs. prior-year quarter
-$15 million YOY FX impact, or -6%
-9% sequentially in constant currency
Diluted EPS $0.78 -43% vs. prior-year quarter -22% sequentially
Diluted shares of 19.3 million, -4% year-over-year
Active Customers 474,000 -18% vs. prior-year quarter -15% sequentially

“The challenging operating environment in Asia Pacific and the strengthening U.S. dollar negatively affected our operating results in the third quarter,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“COVID-related disruptions and challenging economic conditions resulting from those disruptions negatively impacted our results in several key Asia Pacific markets where city-wide lockdowns and other COVID restrictions persisted. This difficult operating environment has impacted our entire industry.”
Guest continued,
“While we remain committed to our long-term business strategy,

Read more...

Hot Business News Today

USANA Q2 Revenue Down 21% To $264 Million

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 2, 2022.

Second quarter net sales were $264 million as compared with $337 million during the second quarter of the prior year.
Second quarter diluted EPS totaled $1.00 versus $1.87 during the second quarter of 2021.
Company reiterates fiscal 2022 net sales and diluted EPS outlook of $1.015 billion to $1.065 billion and $3.85 to $4.45, respectively.

“As indicated in our preliminary results release on July 6th, we continue to experience COVID-related disruptions in several key markets, including mainland China. This caused participation in sales programs, Active Customer counts, and financial performance to come in lower than anticipated,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“Although many of these disruptions were outside of our control, and while we faced a tough year-over year comparable due to the timing of a successful sales program in 2021, our second quarter results were not up to our standards.
Nevertheless, we remain committed to our business strategy which we believe will deliver sustained, long-term growth in customer counts, net sales, and EPS.
Important elements of this strategy include

enhancing digital experience for our customers to improve the overall online shopping experience;
improving

Read more...

Hot Business News Today

USANA Q2 Preliminary Sales Down 21% To $265 Million

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022.
The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021.
“Our sales performance during the second quarter was below expectations, as COVID-related lockdowns, restrictions, and other disruptions continued in mainland China and other markets,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“These challenges were particularly disruptive to the regional sales program we offered in several key markets during the quarter, and ultimately caused participation in the program, sales results and active customer counts to come in lower than anticipated.
Importantly, this program was designed to be a catalyst for sales and customer growth not only during the quarter, but also in the second half of the year. As a result of this and the continued uncertainty surrounding the operating environment going forward, we anticipate softer sales and customer counts in the second half of the year.”
“We continue to

Read more...

Hot Business News Today

USANA Q3 Revenue Up 13.4% To $296.8 Million

by  •  • 0 Comments

Third quarter net sales of$296.8 million, an increase of 13.4% year-over-year

Third quarter diluted earnings per share increased 27.8% year-over-year to$1.24

Total Active Customers increased 9.2% year-over-year to 615,000

Board increases share repurchase authorization

SALT LAKE CITY–(BUSINESS WIRE)– USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 29, 2018.
Financial Performance
For the third quarter of 2018, net sales were $296.8 million, compared with $261.8 million in the prior-year period, a 13.4% increase year-over-year. Unfavorable currency exchange rates negatively impacted net sales by $6.2 million for the quarter as compared to the prior year. The Company’s skin and personal care product category contributed approximately $9.5 million in incremental sales for the quarter. The Company’s total number of active Customers increased 9.2% year-over-year to 615,000.
Net earnings for the third quarter increased 30.6% to $31.0 million, compared with net earnings of $23.8 million reported in the prior-year period. Earnings per diluted share increased to $1.24, an increase of 27.8% on a year-over-year basis. The increase in net earnings was due primarily to higher net sales and lower relative operating expenses compared to the prior year period. Weighted average diluted shares outstanding were 25.0 million for the third quarter of 2018, compared with diluted shares of 24.6 million in the prior-year period.
“We

Read more...

Hot Business News Today

USANA On List Of Most Trustworthy Public Companies In The USA

by  •  • 0 Comments

Trust is a vital factor for consumers and investors when looking into a company — and for USANA, trust is everything.
To this end, USANA has been selected by TGF Analytics as one of “America’s Most Trustworthy Public Companies.”
USANA was ranked fourth among “small/mid cap” companies with an A+ rating — something only five percent of companies researched achieved.
The rankings were based on dozens of factors in five key areas: Financial Governance, Environmental, Social & Corporate Governance (ESG), Quality of Earnings, Relative Risk, and Market-Implied Governance.
“USANA is a company that prides itself on being trustworthy, whether it’s from the overall quality of our products to the information we provide to our investors,”
said Kevin Guest, USANA’s chief executive officer.
“We are delighted to be recognized for our efforts in building trust with the public, and would also like to congratulate the other companies on this prestigious list.”
“Trust is a keystone to all good relationships — those between investor and the company in which the investment is placed, between creditors and the recipients of credit, between customers and businesses they patronize, employees and the workplace, suppliers and with whom they contract, and more,” said David R. Koenig, founding principal of TGF Analytics. “Trust

Read more...

Hot Business News Today

USANA Q2 Sales Up 17% To $301 Million

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its fiscal second quarter ended June 30, 2018.
Record second quarter net sales of $301.5 million, an increase of 17.3% year-over-year
 
Second quarter diluted earnings per share increased 46.2% year-over-year to $1.36 per share
Financial Performance
For the second quarter of 2018, net sales were $301.5 million, compared with $257.1 million in the prior-year period, a 17.3% increase year-over-year. Favorable currency exchange rates positively impacted net sales by $12.5 million for the quarter as compared to the prior-year.
Celavive, the Company’s new skincare line, contributed approximately $7 million in incremental sales for the quarter. In markets where Celavive has launched, skin and personal care products accounted for 9.5% of overall sales in the second quarter of 2018, versus 5.7% a year ago. The Company’s total number of active Customers increased 5.3% year-over-year to 597,000.
Net earnings for the second quarter increased 45.8% to $33.9 million, compared with net earnings of $23.3 million reported in the prior-year period. Earnings per diluted share increased to $1.36 per diluted share, an increase of 46.2% on a year-over-year basis.
The increase in net earnings was due primarily to higher net sales and lower relative operating expenses compared to the prior year period. Costs related to China and the Company’s internal investigation into its China operations were nominal during the second

Read more...

Hot Business News Today

USANA Q1 Sales Up 14.4% To $292 Million

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its fiscal first quarter ended March 31, 2018.
Financial Performance
For the first quarter of 2018, net sales were $292.0 million compared with $255.3 million in the prior-year period, or a 14.4% increase year-over-year.
Favorable currency exchange rates positively impacted net sales by $16.4 million for the quarter. Targeted product promotions offered by the Company during the quarter contributed approximately $11 million to net sales and the Company’s launch of its new skincare line, Celavive, also contributed approximately $9 million in incremental sales for the quarter.

The Company’s total number of active Customers increased 1.9% year-over-year to 585,000.

The Company reported net earnings for the first quarter of $28.9 million, compared with net earnings of $21.4 million reported in the prior-year period. Earnings per diluted share increased to $1.19 per diluted share, an increase of 38.4% on a year-over-year basis.
The increase in net earnings was due primarily to higher net sales, lower relative operating expenses and a lower effective tax rate of 34.2% compared to 36% during the prior year period. Costs related to China and the Company’s internal investigation into its China operations were nominal during the first quarter of 2018 as compared to approximately $2.4 million, after tax, during the prior year period.

“We are off to a solid start to the year as

Read more...

Hot Business News Today

USANA Expands To Romania, Germany, Italy, And Spain

by  •  • 0 Comments

USANA (NYSE: USNA), The Cellular Nutrition Company, is proud to announce the official opening date of its four new European markets as June 20th, 2018.
USANA has grown from its humble beginnings in 1992 to a global health and wellness leader, and the company looks to cement its place in the industry with their upcoming European expansion.
The new markets—Romania, Germany, Italy, and Spain—will increase USANA’s global footprint from 20 to 24 markets worldwide.
“Further expansion of USANA in Europe broadens our international reach, and we couldn’t be more excited,”
said USANA CEO, Kevin Guest. ”
When Dr. Wentz founded this company, he wanted to provide personal and financial health and wealth to everyone in the world, and this expansion helps Dr. Wentz get one step closer to his ultimate goal.”
“I have seen USANA grow from being in a handful of markets, to 20, and now to 24, it’s truly amazing to see what this company has become,” said USANA chief field development officer, David Mulham.
“This expansion will provide the people of Romania, Germany, Italy, and Spain the potential opportunity for financial freedom and the access to some of the highest quality nutritional and skincare products on the market.”
The new European markets will be

Read more...

Hot Business News Today

USANA Year 2017 Sales Up 4% To $1.047 Billion

by  •  • 0 Comments

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full-year ended December 30, 2017.
Financial Performance
For the fourth quarter of 2017, net sales were $273.1 million compared with $252.9 million in the prior-year period, or an 8.0% increase year-over-year. The weakening of the U.S. dollar positively impacted net sales by $7.4 million for the quarter.
The Company’s total number of active Customers2 increased modestly year-over-year to 565,000.
The Company reported a net loss for the fourth quarter of $5.9 million, or $0.24 loss per share, compared with net earnings of $21.9 million, or $0.87 per diluted share during the prior-year period. The net loss is attributable to a one-time, non-cash charge of $30.1 million, or $1.24 per diluted share, related to the U.S. tax reform3 (the “Tax Reform”) enacted on December 22, 2017.
The charge is largely due to foreign tax credits and other deferred tax assets that the Company will not be able to realize under the new tax laws. Costs related to China and the Company’s internal investigation into its China operations, which was first disclosed in February 2017, negatively impacted fourth quarter net earnings by approximately $2.7 million after tax and earnings per diluted

Read more...